Lipocalin 2 Diminishes Invasiveness and Metastasis of Ras-transformed Cells*

Lipocalin 2, an iron-siderophore-binding protein, converts embryonic kidney mesenchyme to epithelia. We found that lipocalin 2 could also convert 4T1-Ras-transformed mesenchymal tumor cells to an epithelial phenotype, increase E-cadherin expression, and suppress cell invasiveness in vitro and tumor growth and lung metastases in vivo. The Ras-MAPK pathway mediated the epithelial to mesenchymal transition in part by increasing E-cadherin phosphorylation and degradation. Lipocalin 2 antagonized these effects at a point upstream of Raf activation. Lipocalin 2 action was enhanced by iron-siderophore. These data characterize lipocalin 2 as an epithelial inducer in Ras malignancy and a suppressor of metastasis.

[1]  C. Savage-Dunn,et al.  Detection of intracellular iron by its regulatory effect. , 2004, American journal of physiology. Cell physiology.

[2]  D. Morrison,et al.  Signal Transduction: IMPlications for Ras-Dependent ERK Signaling , 2004, Current Biology.

[3]  P. M. Campbell,et al.  Oncogenic Ras and its role in tumor cell invasion and metastasis. , 2004, Seminars in cancer biology.

[4]  C. Rinker-Schaeffer,et al.  A New Look at an Old Problem: The Survival and Organ-Specific Growth of Metastases , 2004, Science's STKE.

[5]  A. Friedl,et al.  Neutrophil Gelatinase-associated Lipocalin in Normal and Neoplastic Human Tissues. Cell Type-specific Pattern of Expression , 1999, The Histochemical Journal.

[6]  D. Chopin,et al.  Epithelial Cell Plasticity in Development and Tumor Progression , 2004, Cancer and Metastasis Reviews.

[7]  H. Beug,et al.  Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis , 2003, Nature Reviews Molecular Cell Biology.

[8]  K. Mori,et al.  Iron, lipocalin, and kidney epithelia. , 2003, American journal of physiology. Renal physiology.

[9]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[10]  J. Stockand,et al.  Targeted degradation of ENaC in response to PKC activation of the ERK1/2 cascade. , 2003, American journal of physiology. Renal physiology.

[11]  E. Cable,et al.  Expression of E-cadherin and other paracellular junction genes is decreased in iron-loaded hepatocytes. , 2003, The American journal of pathology.

[12]  J. Downward.  Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.

[13]  C. Jun,et al.  Involvement of p38 MAP kinase during iron chelator-mediated apoptotic cell death. , 2002, Cellular immunology.

[14]  H. Erdjument-Bromage,et al.  An iron delivery pathway mediated by a lipocalin. , 2002, Molecular cell.

[15]  R. Strong,et al.  The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. , 2002, Molecular cell.

[16]  A. Mammoto,et al.  Intravenous anesthetic, propofol inhibits invasion of cancer cells. , 2002, Cancer letters.

[17]  Kornelia Polyak,et al.  Cellular and molecular targets of estrogen in normal human breast tissue. , 2002, Cancer research.

[18]  V. Sukhatme,et al.  Endostatin is a potential inhibitor of Wnt signaling , 2002, The Journal of cell biology.

[19]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[20]  R. Kemler,et al.  E-cadherin is a survival factor for the lactating mouse mammary gland , 2002, Mechanisms of Development.

[21]  J. Thiery.  Epithelial–mesenchymal transitions in tumour progression , 2002, Nature Reviews Cancer.

[22]  V. Sukhatme,et al.  Endostatin Causes G1 Arrest of Endothelial Cells through Inhibition of Cyclin D1* , 2002, The Journal of Biological Chemistry.

[23]  W. Birchmeier,et al.  Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex , 2002, Nature Cell Biology.

[24]  J. G. Teodoro,et al.  Induction of Apoptosis by a Secreted Lipocalin That is Transcriptionally Regulated by IL-3 Deprivation , 2001, Science.

[25]  B. Redl,et al.  Molecular Cloning of a Novel Lipocalin-1 Interacting Human Cell Membrane Receptor Using Phage Display* , 2001, The Journal of Biological Chemistry.

[26]  D R Flower,et al.  Beyond the superfamily: the lipocalin receptors. , 2000, Biochimica et biophysica acta.

[27]  T. Bratt,et al.  Lipocalins and cancer. , 2000, Biochimica et biophysica acta.

[28]  J. Trendel,et al.  Vimentin expression in human squamous carcinoma cells: Relationship with phenotypic changes and cadherin‐based cell adhesion , 2000, Journal of cellular biochemistry.

[29]  P. McNutt,et al.  Cadherins and their connections: adhesion junctions have broader functions. , 1999, Current opinion in cell biology.

[30]  T. Tsukamoto,et al.  Cell-Cell Dissociation upon Epithelial Cell Scattering Requires a Step Mediated by the Proteasome* , 1999, The Journal of Biological Chemistry.

[31]  H. Iba,et al.  Fra-2-positive autoregulatory loop triggered by mitogen-activated protein kinase (MAPK) and Fra-2 phosphorylation sites by MAPK. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[32]  C. L. Adams,et al.  Cytomechanics of cadherin-mediated cell-cell adhesion. , 1998, Current opinion in cell biology.

[33]  M. Dewhirst,et al.  Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  H. Yoshikawa,et al.  Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung , 1998, International journal of cancer.

[35]  R. Strong,et al.  Expression, purification, crystallization and crystallographic characterization of dimeric and monomeric human neutrophil gelatinase associated lipocalin (NGAL). , 1998, Acta crystallographica. Section D, Biological crystallography.

[36]  J. Cowland,et al.  Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. , 1997, Genomics.

[37]  D R Flower,et al.  The lipocalin protein family: structure and function. , 1996, The Biochemical journal.

[38]  M. Kress,et al.  An apparent autocrine mechanism amplifies the dexamethasone- and retinoic acid-induced expression of mouse lipocalin-encoding gene 24p3. , 1996, Gene.

[39]  B. Nielsen,et al.  Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. , 1996, Gut.

[40]  C. Vanderburg,et al.  E-cadherin transforms embryonic corneal fibroblasts to stratified epithelium with desmosomes. , 1996, Acta anatomica.

[41]  E. Hay.  An overview of epithelio-mesenchymal transformation. , 1995, Acta anatomica.

[42]  W. Birchmeier,et al.  Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. , 1994, Biochimica et biophysica acta.

[43]  L. Lehman-Mckeeman,et al.  Alpha 2u-globulin is the only member of the lipocalin protein superfamily that binds to hyaline droplet inducing agents. , 1992, Toxicology and applied pharmacology.

[44]  K. Raymond,et al.  Solution equilibria of enterobactin and metal-enterobactin complexes , 1991 .

[45]  B. Hedlund,et al.  Role of iron in postischemic renal injury in the rat. , 1988, Kidney international.